Literature DB >> 26018849

Application of 3D imaging in the real-time US-CT fusion navigation for minimal invasive tumor therapy.

Wenbo Wu1, Yingfeng Xue2, Dong Wang3, Xiaoguang Li4, Jin Xue5,6, Shaobo Duan1, Fang Wang7.   

Abstract

PURPOSE: Image-guided minimally invasive treatment (IG-MIT) has been widely used for local therapy of both benign and malignant tumors. However, precise needle targeting is a very important step in the minimally invasive treatment. Nowadays, minimally invasive treatment is usually performed with the guidance of the two-dimensional (2D) image. The tip of the puncture needle is difficult to place with precise positioning into the three-dimensional (3D) space of the tumor. This study was an experimental ex vivo study in porcine liver and heart samples with internal targets, focusing on the accuracy with the guidance of the real-time 3D imaging using a self-developed real-time ultrasonography and preoperative computed tomography (CT) fusion navigation system for minimal invasive tumor (liver tumor and uterine fibroid) therapy.
METHODS: There are thirty porcine liver samples and thirty porcine heart samples used in the experiments. The average weight of the porcine liver samples was 2216.8 g, and the average weight of the porcine heart samples was 510.5 g. We conducted statistical analysis of the experimental results obtained by five medical students and five interventional radiologists.
RESULTS: The puncture precision of the needle placement under the guidance of 3D imaging was significantly higher than that of the other groups, and the assistant function is more obvious for medical students than that for interventional radiologists [Formula: see text]. Assistant function of the US-CT fusion imaging is higher than that of the first group too [Formula: see text]. The precision of the puncture with guidance of the 3D imaging was very satisfied in the fact that it was found that there was a mean discrepancy of [Formula: see text] (medical students) and [Formula: see text] (interventional radiologists) in porcine livers and there was a mean discrepancy of [Formula: see text] (medical students) and [Formula: see text] (interventional radiologists) in porcine hearts.
CONCLUSIONS: Experimental results showed that the accuracy of needle targeting can be improved with the guidance of the real-time 3D imaging than that with the guidance of both 2D US images and US-CT fusion images in IG-MIT. Assistant function of 3D imaging is obviously for medical students.

Entities:  

Keywords:  3D image guidance; Minimally invasive treatment; Precise needle targeting; US–CT fusion navigation; Ultrasound guidance

Mesh:

Year:  2015        PMID: 26018849     DOI: 10.1007/s11548-015-1224-z

Source DB:  PubMed          Journal:  Int J Comput Assist Radiol Surg        ISSN: 1861-6410            Impact factor:   2.924


  24 in total

1.  In-vivo non-invasive motion tracking and correction in high intensity focused ultrasound therapy.

Authors:  Fabrice Marquet; Mathieu Pernot; Jean-Francois Aubry; Mickael Tanter; Gabriel Montaldo; Mathias Fink
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2006

2.  The assistant function of three-dimensional information for I125 particle implantation.

Authors:  Wenbo Wu; Jin Xue; Ping Liang; Zhigang Cheng; Min Zhang; Mengjuan Mu; Cai Qi
Journal:  IEEE J Biomed Health Inform       Date:  2014-01       Impact factor: 5.772

Review 3.  Image-guided fusion and navigation: applications in tumor ablation.

Authors:  Liat Appelbaum; Sam Y Mahgerefteh; Jacob Sosna; S Nahum Goldberg
Journal:  Tech Vasc Interv Radiol       Date:  2013-12

Review 4.  State of the art 3D imaging of abdominal organs.

Authors:  M A Muller; B Marincek; T Frauenfelder
Journal:  JBR-BTR       Date:  2007 Nov-Dec

5.  Computerized CT-based 3D visualization technique in living related liver transplantation.

Authors:  J Harms; M Bartels; H Bourquain; H O Peitgen; T Schulz; T Kahn; J Hauss; J Fangmann
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

6.  Prototype of an intraoperative navigation and documentation system for laparoscopic radiofrequency ablation: first experiences.

Authors:  P Hildebrand; S Schlichting; V Martens; A Besirevic; M Kleemann; U Roblick; L Mirow; C Bürk; A Schweikard; H-P Bruch
Journal:  Eur J Surg Oncol       Date:  2007-06-11       Impact factor: 4.424

7.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

8.  A semi-automatic approach to the segmentation of liver parenchyma from 3D CT images with Extreme Learning Machine.

Authors:  W Huang; Z M Tan; Z Lin; G-B Huang; J Zhou; C K Chui; Y Su; S Chang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2012

9.  Feasibility study on energy prediction of microwave ablation upon uterine adenomyosis and leiomyomas by MRI.

Authors:  M Xia; Z Jing; H Zhi-Yu; C Jian-Ming; Z Hong-Yu; X Rui-Fang; Y Yu; H Yan-Li; D Bao-Wei
Journal:  Br J Radiol       Date:  2014-06-20       Impact factor: 3.039

10.  Preparing the anatomical model for ablation of unresectable liver tumor.

Authors:  Dominik Spinczyk
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-05-26       Impact factor: 1.195

View more
  2 in total

1.  The value of 3D visualization operative planning system in ultrasound-guided percutaneous microwave ablation for large hepatic hemangiomas: a clinical comparative study.

Authors:  Xin Li; Chao An; Fangyi Liu; Zhigang Cheng; Zhiyu Han; Xiaoling Yu; Linan Dong; Jie Yu; Ping Liang
Journal:  BMC Cancer       Date:  2019-06-07       Impact factor: 4.430

Review 2.  Application of Multimodality Imaging Fusion Technology in Diagnosis and Treatment of Malignant Tumors under the Precision Medicine Plan.

Authors:  Shun-Yi Wang; Xian-Xia Chen; Yi Li; Yu-Ying Zhang
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.